With an ever growing number of genetic tests being marketed directly to consumers — check out this story in the Wall Street Journal that reports on Myriad Genetics’ breast-cancer-gene test seeing a 55% increase in sales after an $8 million advertising blitz — people are going to have to be even more discriminating.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.